Ankit Madan, MD| Medical Oncology | MedStar Health

Ankit Madan, MD
Provider is directly employed by MedStar Health

Specialities: Medical Oncology

Languages: English

About me

Dr. Madan attended medical school at Gajra Raja Medical College in India prior to completing an internal medicine residency and a hematology and oncology fellowship at University of Alabama. He is board certified in internal medicine, hematology, and medical oncology.

As a hematologist and oncologist, Dr. Madan cares for patients with a variety of conditions, including benign and malignant hematology disorders (leukemia, lymphoma), melanoma, sarcoma and cancers of the breast, colon, kidney, liver, lung, prostate and ovaries at MedStar Georgetown Cancer Institute at MedStar Southern Maryland Hospital Center.

Philosophy of care
Dr. Madan believes in providing the latest, state-of-the-art, evidence-based cancer care with compassion, empathy, and respect. He uses a multidisciplinary approach in managing all malignancies to optimize patient outcomes and supports patients and their families in their respective goals of care.

“Our vision is to make cancer care in Southern Maryland highly accessible, and available to the community. Cancer affects patients and their families, and by being their partner in this difficult journey, I hope to alleviate some of the stress, and anxiety associated with this disease. "

Clinical areas of focus

  • Adenocarcinoma Of Lung
  • Bladder Cancer
  • Breast Cancer
  • Colorectal Malignancy
  • Esophageal Cancer Chemotherapy
  • Kidney Cancer
  • Leukemia
  • Melanoma
  • Mesothelioma
  • Non Small Cell Lung Cancer
  • Pancreas Cancer
  • Prostate Cancer
  • Rectal Cancer
  • Sarcoma
  • Seminoma
  • Testicular Cancer
Show More

Conditions and procedures

Conditions I treat

  • Abdominal Cancer
  • Adenocarcinoma Of Lung
  • Adenocarcinoma Of The Bladder
  • Advanced Malignancies
  • Appendiceal Cancer
  • Autoimmune Cytopenia
  • Benign Neoplasm Bone
  • Bile Duct Mass
  • Bladder Cancer
  • Brain Metastases
  • Breast Cancer
  • Cancer
  • Cancer Pain
  • Cancer Survivor
  • Carcinoma Of Unknown Primary
  • Colorectal Malignancy
  • Ductal Carcinoma In Situ (DCIS)
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer
  • Gallbladder Cancer
  • Gastroesophageal Junction Cancer
  • Gastrointestinal (GI) Cancer
  • Genitourinary Cancers
  • Head And Neck Tumors
  • Hemolytic Uremic Syndrome
  • Hereditary Cancer Risk
  • Intestinal Cancer
  • Kidney Cancer
  • Large Cell Cancer Of The Lung
  • Large Cell Neuroendocrine Tumors
  • Leukemia
  • Liver Cancer
  • Liver Metastases
  • Long Term Side Effects Of Cancer Treatment
  • Lung Cancer
  • Lung Mass
  • Lymphoma
  • Lymphoproliferative Disorder
  • Malignant Carcinoid Tumor Of Colon
  • Malignant Lung Tumors
  • Mediastinal Lymphadenopathy
  • Melanoma
  • Mesothelioma
  • Muscle Invasive Bladder Cancer
  • Myeloproliferative Diseases
  • Nodular Lymphocyte Predominant Hodgkin Lymphoma
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Non Small Cell Lung Cancer
  • Non-Muscle Invasive Bladder Cancer
  • Pancreas Cancer
  • Plasma Cell Dyscrasia
  • Prostate Cancer
  • Pulmonary Metastases
  • Rectal Cancer
  • Refractory Anemia With Excess Blasts
  • Refractory Cytopenia
  • Relapsed Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • Sarcoma
  • Seminoma
  • Side Effects Of Cancer Treatment
  • Smoldering Multiple Myeloma
  • Solid Tumors
  • Squamous Cell Carcinoma Of Bladder
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Tracheal Cancer
  • Waldenstrom Macroglobulinemia
Show All Show Less

Procedures I perform

  • Abdominal Cancer Chemotherapy
  • Adjuvant Chemotherapy
  • Adjuvant Chemotherapy
  • Anorectal Cancer Chemotherapy
  • Appendiceal Cancer Chemotherapy
  • Biliary Tract Cancer Chemotherapy
  • Biological Targeted Therapy
  • Bladder Cancer Chemotherapy
  • Brain Cancer Chemotherapy
  • Breast Cancer Biological Targeted Therapy
  • Breast Cancer Chemotherapy
  • Cancer Chemotherapy
  • Cancer Genomics
  • Cervical Cancer Chemotherapy
  • Chemoradiation
  • Colon Cancer Chemotherapy
  • Colorectal Cancer Chemotherapy
  • Early Detection Of Cancer
  • Endometrial Cancer Chemotherapy
  • Esophageal Cancer Chemotherapy
  • Gallbladder Cancer Chemotherapy
  • Head And Neck Cancer Chemotherapy
  • Hormone Based Chemotherapy
  • Hypopharyngeal Cancer Chemotherapy
  • Laryngeal Cancer Chemotherapy
  • Liquid Biopsy Testing
  • Liver Cancer Chemotherapy
  • Mouth Cancer Chemotherapy
  • Nasal Cavity Cancer Chemotherapy
  • Nasopharyngeal Cancer Chemotherapy
  • Non Steroidal Aromatase Inhibitors
  • Ovarian Cancer Chemotherapy
  • Pancreatic Cancer Chemotherapy
  • Personalized Cancer Therapy
  • Pleural Cancer Chemotherapy
  • Prostate Cancer Chemotherapy
  • Renal Cell Carcinoma Immunotherapy
  • Small Cell Lung Cancer Chemotherapy
  • Small Intestine Cancer Chemotherapy
  • Stomach Cancer Chemotherapy
  • Systemic Therapy
  • Targeted Molecular Therapy
  • Testicular Cancer Chemotherapy
  • Throat Cancer Chemotherapy
  • Tongue Cancer Chemotherapy
  • Uterine Cancer Chemotherapy
  • Vaginal Cancer Chemotherapy
Show All button Press enter to expand Show Less

Practice locations

Distance from Change LocationEnter your Location

7501 Surratts Road
Suite 108
Clinton, MD, 20735

301-877-5610

Fax 301-868-7415

Get Directions

miles away

Fax 301-868-7415

Insurance

MedStar Medical Group accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Medical Group, please call your insurance company.

  • List of insurance plans we accept
    • Aetna Elect Choice/ EPO (Aetna Health Fund) Innovation Health: Network Only Plus
    • Aetna Quality Point of Service (POS)
    • Aetna USAccess (POS)
    • Aetna Student Health Insurance
    • Aetna Medicare Advantage HMO & PPO Plans
    • CFBCBS BlueChoice HMO
    • CFBCBS Blue Choice Opt Out Plus Open Access (POS)
    • CFBCBS Maryland Point of Service Plan (MPOS)
    • CFBCBS Federal Employee Program (Std. & Basic PPO)
    • CFBCBS Maryland Indemnity or PPO
    • CFBCBS (NCA) Indemnity
    • CIGNA HMO & Network (HMO)
    • CIGNA POS/Network POS
    • Great-West Healthcare POS/CIGNA
    • CIGNA Indemnity
    • Coventry Health Care of Virginia
    • Coventry of Delaware HMO/PPO
    • First Health PPO
    • FIRST HEALTH
    • Tricare Prime
    • Tricare Standard
    • Tricare Extra (Indemnity)
    • Tricare for Life (Medicare Supplemental Plan)
    • MedStar Family Choice - Maryland Health Choice
    • MedStar Select (MedStar Associates' Plan)
    • MedStar Medicare Choice
    • United Healthcare Select HMO - EPO/NPP
    • United Healthcare Select Plus (POS)
    • United Healthcare Choice Plus
    • United Student Resources
    • M.D. IPA (HMO)
    • M.D. IPA Preferred (POS)
    • Optimum Choice Preferred (POS) & OCI Direct (HMO)
    • Mamsi Life & Health (Indem./PPO)
    • Aetna Worker's Compensation Network
    • Coventry Health Care National Network PPO
    • Private Health Care Systems (PHCS) (PPO)
    • United Healthcare Options (PPO) (includes Empire PPO, GEHA, Compass Rose)
    • OneNet PPO, Inc.
    • United Healthcare Choice
    • United Healthcare Core Essential (HMO)
    • Optimum Choice
    • United Healthcare Navigate
    • United Healthcare Compass (HMO)
    • CIGNA HMO Open Access (OA)
    • Network OA
    • POS OA & OA Plus
    • CIGNA EPO
    • PPO and PPO Plus
    • Choice Fund PPO
    • CFBSBC Blue Preferred PPO
    • HealthyBlue PPO
    • CFBCBS Blue Choice Opt Out Open Access
    • BlueChoice Open Access
    • Blue Choice Advantage & Healthy Blue (HMO, POS)
    • Aetna Traditional Choice (PPO)
    • Innovation Health: Indemnity
    • Aetna Open Choice (PPO)
    • Innovation Health: PPO
    • Aetna Managed Choice (POS)
    • Innovation Health: POS Plus
    • Aetna Elect Choice/ Open Access (POS)
    • Innovation Health: Open Network Only Plus
    • Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
    • Innovation Health: POS
    • Open HMO
    • Opoen HMO Option
    • Open EPO Plus
    • Aetna Managed Choice Open Access (POS)
    • Choice POS & Choice POS II
    • Innovation Health: Open POS Plus
    • Open POS II
    • Aetna HMO
    • Select HMO/HealthFund/Health Network
    • Aetna Innovations: HMO & EPO Plus

Education

Board Certification: American Board of Internal Medicine, Hematology

Board Certification: American Board of Internal Medicine, Internal Medicine

Board Certification: American Board of Internal Medicine, Medical Oncology

Fellowship Program: University of Alabama Birmingham Hospital (2017)

Residency Program: University of Alabama Birmingham HospitalHighlands (2014)

Medical School: Gajra Raja Medical College (2009)

News and publications


  1. Comprehensive review of implications of COVID-19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic

    Ankit Madan
    , Joshua Siglin, Aleem Khan

    Cancer Medicine 2020; 9(24)9205-9218


  2. A narrative review of the evolving role of immunotherapy in the management of esophageal and gastric cancer 

    Ankit Madan,
    Hope E. Uronis , John H. Strickler

    J Gastrointest Oncol 2022;13(4) 2007-2019



  3. Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients

    Ankit Madan
    , Benjamin Jones, Rodolfo Bordoni, Mansoor Saleh, Mary Jerome, Deborah Miley, Bradford Jackson, Francisco Robert

    Cancer Chemother Pharmacol 2016 Sep;78(3):509-15 



  4. Localized small cell carcinoma of the breast: a case report and review of current evidence

    Linsey Atchison,Thomas Hardy,Tara Mancl, Brian Quaranta, Ankit Madan

    Case Rep Oncol 2021;14:761–766



  5. CNS Involvement in a Patient with Chronic Myeloid Leukemia

    Marcus A. Healey, Daniel J. Allendorf , Uma Borate , and Ankit Madan

    Volume 2021 |Article ID 8891376 Case reports in hematology



  6. CXCR2 Mediates Distinct Neutrophil Behavior in Brain Metastatic Breast Tumor

    Simrit Safarulla, Ankit Madan, Fei Xing, Arvind Chandasekaran

    Cancers 2022, 14(3), 515



  7. Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma

    Arindam P. Ghosh, Christopher D. Willey, Joshua C. Anderson, Karim Welaya, Dongquan Chen, Amitkumar Mehta, Pooja Ghatalia, Ankit Madan, Gurudatta Naik, Sunil Sudarshan, Guru Sonpavde

    Oncotarget 2017 Apr 25; 8(17): 29220–29232.



  8. Prevalence of Measurable disease in metastatic castration-resistant prostate cancer

    Guru Sonpavde, Ankit Madan, Mary K. Baker, Jori E. May, Gurudutta Naik, Sejong Bae

    Clin Genitourin Cancer. 2017 Apr 26. 




  9. Genomics and precision medicine: kidney cancer

    Ankit Madan, David M.Nanus

    Book: Genomic and Precision Medicine (Third Edition)

    2022, Pages 285-295



  10. Adult Wilms’ Tumor chapter

    Book: Rare Genitourinary tumors, Lance Pagliaro

    Ankit Madan, Guru Sonpavde

    DOI 10.1007/978-3-319-30046-75